Detalles de la búsqueda
1.
Identification of potential inhibitor against Leishmania donovani mitochondrial DNA primase through in-silico and in vitro drug repurposing approaches.
Sci Rep
; 14(1): 3246, 2024 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332162
2.
Discovering potential inhibitors against SARS-CoV-2 by targeting Nsp13 Helicase.
J Biomol Struct Dyn
; 40(22): 12062-12074, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-34455933
3.
Evaluation of flavonoids as 2019-nCoV cell entry inhibitor through molecular docking and pharmacological analysis.
Heliyon
; 7(3): e06515, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33748510
4.
Discovering Potential RNA Dependent RNA Polymerase Inhibitors as Prospective Drugs Against COVID-19: An in silico Approach.
Front Pharmacol
; 12: 634047, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33716752
5.
Evaluation of potential drugs against leishmaniasis targeting catalytic subunit of Leishmania donovani nuclear DNA primase using ligand based virtual screening, docking and molecular dynamics approaches.
J Biomol Struct Dyn
; 39(5): 1838-1852, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32141397
6.
Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches.
Infect Genet Evol
; 84: 104451, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32640381
Resultados
1 -
6
de 6
1
Próxima >
>>